首页 | 本学科首页   官方微博 | 高级检索  
     

咪唑克生对体外血脑屏障炎症模型通透性的影响
引用本文:王新施,朱攀,朱振国,夏念格,李佳,郑荣远. 咪唑克生对体外血脑屏障炎症模型通透性的影响[J]. 中国病理生理杂志, 2015, 31(4): 669-674. DOI: 10.3969/j.issn.1000-4718.2015.04.017
作者姓名:王新施  朱攀  朱振国  夏念格  李佳  郑荣远
作者单位:温州医科大学附属第一医院神经内科, 浙江 温州 325000
基金项目:浙江省自然科学基金资助项目(No.LQ12H09002);温州市科技计划项目(No.Y20140283)
摘    要:目的:观察咪唑克生(idazoxan,IDA)对体外血脑屏障(blood-brain barrier,BBB)炎症模型的通透性、紧密连接蛋白ZO-1表达和分布及基质金属蛋白酶-9(matrix metalloproteinases-9,MMP-9)和MMP-9抑制物——金属蛋白酶组织抑制物-1(tissue inhibitor of metalloproteinase-1,TIMP-1)表达的影响。方法:采用培养7 d的小鼠脑微血管内皮细胞株b.End3建立体外BBB模型,采用TNF-α(10 nmol/L)处理24 h诱导BBB炎症模型,并对BBB炎症模型分别采用IDA 50、100、200μmol/L预处理6 h以观察IDA对BBB炎症模型的作用。通过检测异硫氰酸荧光标记的葡聚糖通过率来确立模型的通透性,采用Western blot法检测紧密连接蛋白ZO-1的表达,通过免疫荧光法观察ZO-1的分布情况,并通过RT-PCR法检测MMP-9/TIMP-1的表达。结果:培养7 d的b.End3细胞汇合成稳定的单层连接,有较好的屏障功能,而采用TNF-α处理24 h后诱导的BBB炎症模型的通透性明显升高,紧密连接蛋白ZO-1在膜上的表达明显减少、不连续,Western blot法显示ZO-1蛋白表达水平明显下降,MMP-9的表达明显升高;而采用IDA 50、100、200μmol/L预处理6 h能明显降低其通透性,增加ZO-1蛋白的表达和改善ZO-1的分布异常,降低MMP-9的表达,其中200μmol/L IDA作用最明显,差异有统计学意义(P0.01)。结论:IDA能够直接作用于脑血管内皮细胞,降低TNF-α诱导的体外BBB炎症模型MMP-9的表达,增加紧密连接蛋白ZO-1的表达、修复紧密连接ZO-1的异常分布,从而改善其异常增高的通透性。

关 键 词:咪唑克生  血脑屏障  紧密连接  ZO-1  基质金属蛋白酶-9  组织型基质金属蛋白酶抑制物-1  
收稿时间:2015-01-07

Effect of idazoxan on permeability of inflammatory blood-brain barrier model in vitro
WANG Xin-shi;ZHU Pan;ZHU Zhen-guo;XIA Nian-ge;LI Jia;ZHENG Rong-yuan. Effect of idazoxan on permeability of inflammatory blood-brain barrier model in vitro[J]. Chinese Journal of Pathophysiology, 2015, 31(4): 669-674. DOI: 10.3969/j.issn.1000-4718.2015.04.017
Authors:WANG Xin-shi  ZHU Pan  ZHU Zhen-guo  XIA Nian-ge  LI Jia  ZHENG Rong-yuan
Affiliation:Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
Abstract:AIM: To study the effect of idazoxan on the permeability of inflammatory blood-brain barrier (BBB) model in vitro and the expression of tight junction protein ZO-1.METHODS: In vitro BBB model was established by murine brain endothelial cell line bEnd.3 incubated for 7 d. The cells were treated with TNF-α (10 nmol/L) for additional 24 h to establish the inflammatory BBB model, which was pretreated with IDA at doses of 50, 100 and 200 μmol/L, respectively. The permeability was measured using fluorescein isothiocyanate-conjugated dextran (FD-40, MW 40,000), the expression of ZO-1 was detected by Western blot analysis, the distribution of ZO-1 was observed by immunofluorescence, and the mRNA expression of MMP-9/TIMP-1 was measured by RT-PCR.RESULTS: After incubated for 7 d, b.End3 cells converged to be confluent monolayer with low permeability. The inflammatory BBB model induced by TNF-α treatment displayed much higher permeability with decreased expression of tight junction protein ZO-1, destroyed distribution of ZO-1 and increased mRNA expression of MMP-9. When pretreated with IDA, the permeability was greatly decreased, the expression of ZO-1 was greatly increased, the abnormal distribution of ZO-1 was greatly ameliorated and the mRNA expression of MMP-9 was obviously reduced. The effect was most significant in IDA (200 μmol/L)-pretreated group (P<0.01).CONCLUSION: IDA directly acts on brain endothelial cells to reduce the expression of MMP-9, increase the expression of tight junction protein ZO-1 and ameliorate the destroyed distribution of ZO-1 in the inflammatory BBB, thus reversing the abnormally elevated permeability in a inflammatory BBB model in vitro induced by TNF-α.
Keywords:Idazoxan  Blood-brain barrier  Tight junction  ZO-1  Matrix metalloproteinases-9  Tissue inhibitors of metalloproteinase-1
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号